230 related articles for article (PubMed ID: 32245293)
41. Engagement of TLR3, TLR7, and NKG2D regulate IFN-gamma secretion but not NKG2D-mediated cytotoxicity by human NK cells stimulated with suboptimal doses of IL-12.
Girart MV; Fuertes MB; Domaica CI; Rossi LE; Zwirner NW
J Immunol; 2007 Sep; 179(6):3472-9. PubMed ID: 17804388
[TBL] [Abstract][Full Text] [Related]
42. Reduced Expression of Siglec-7, NKG2A, and CD57 on Terminally Differentiated CD56
Zulu MZ; Naidoo KK; Mncube Z; Jaggernath M; Goulder PJR; Ndung'u T; Altfeld M; Thobakgale CF
AIDS Res Hum Retroviruses; 2017 Dec; 33(12):1205-1213. PubMed ID: 28810810
[TBL] [Abstract][Full Text] [Related]
43. Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.
Fregni G; Messaoudene M; Fourmentraux-Neves E; Mazouz-Dorval S; Chanal J; Maubec E; Marinho E; Scheer-Senyarich I; Cremer I; Avril MF; Caignard A
PLoS One; 2013; 8(10):e76928. PubMed ID: 24204708
[TBL] [Abstract][Full Text] [Related]
44. CD33 (Siglec-3) Inhibitory Function: Role in the NKG2D/DAP10 Activating Pathway.
Hernández-Caselles T; Miguel RC; Ruiz-Alcaraz AJ; García-Peñarrubia P
J Immunol Res; 2019; 2019():6032141. PubMed ID: 31143782
[TBL] [Abstract][Full Text] [Related]
45. Tumoral NKG2D alters cell cycle of acute myeloid leukemic cells and reduces NK cell-mediated immune surveillance.
Tang M; Acheampong DO; Wang Y; Xie W; Wang M; Zhang J
Immunol Res; 2016 Jun; 64(3):754-64. PubMed ID: 26740330
[TBL] [Abstract][Full Text] [Related]
46. IDO1 impairs NK cell cytotoxicity by decreasing NKG2D/NKG2DLs via promoting miR-18a.
Zhang J; Han X; Hu X; Jin F; Gao Z; Yin L; Qin J; Yin F; Li C; Wang Y
Mol Immunol; 2018 Nov; 103():144-155. PubMed ID: 30268986
[TBL] [Abstract][Full Text] [Related]
47. Interleukin 10 decreases MICA expression on melanoma cell surface.
Serrano AE; Menares-Castillo E; Garrido-Tapia M; Ribeiro CH; Hernández CJ; Mendoza-Naranjo A; Gatica-Andrades M; Valenzuela-Diaz R; Zúñiga R; López MN; Salazar-Onfray F; Aguillón JC; Molina MC
Immunol Cell Biol; 2011 Mar; 89(3):447-57. PubMed ID: 20714339
[TBL] [Abstract][Full Text] [Related]
48. Suppression of human anti-porcine natural killer cell xenogeneic responses by combinations of monoclonal antibodies specific to CD2 and NKG2D and extracellular signal-regulated kinase kinase inhibitor.
Kim TJ; Kim N; Kim EO; Choi JR; Bluestone JA; Lee KM
Immunology; 2010 Aug; 130(4):545-55. PubMed ID: 20406306
[TBL] [Abstract][Full Text] [Related]
49. Structure-based rational design of a novel chimeric PD1-NKG2D receptor for natural killer cells.
Guo C; Wang X; Zhang H; Zhi L; Lv T; Li M; Lu C; Zhu W
Mol Immunol; 2019 Oct; 114():108-113. PubMed ID: 31351411
[TBL] [Abstract][Full Text] [Related]
50. [The negative regulatory effect of IFN-gamma on cognitive function of human natural killer cells].
Zhang C; Tian ZG; Zhang J; Feng JB; Zhang JH; Xu XQ
Zhonghua Zhong Liu Za Zhi; 2004 Jun; 26(6):324-7. PubMed ID: 15312339
[TBL] [Abstract][Full Text] [Related]
51. Arsenite suppresses IL-2-dependent tumoricidal activities of natural killer cells.
Sumi D; Tsuyama H; Ogawa T; Ogawa M; Himeno S
Toxicol Appl Pharmacol; 2021 Feb; 412():115353. PubMed ID: 33301752
[TBL] [Abstract][Full Text] [Related]
52. BCR/ABL promotes dendritic cell-mediated natural killer cell activation.
Terme M; Borg C; Guilhot F; Masurier C; Flament C; Wagner EF; Caillat-Zucman S; Bernheim A; Turhan AG; Caignard A; Zitvogel L
Cancer Res; 2005 Jul; 65(14):6409-17. PubMed ID: 16024645
[TBL] [Abstract][Full Text] [Related]
53. Human gammadelta T lymphocytes induce robust NK cell-mediated antitumor cytotoxicity through CD137 engagement.
Maniar A; Zhang X; Lin W; Gastman BR; Pauza CD; Strome SE; Chapoval AI
Blood; 2010 Sep; 116(10):1726-33. PubMed ID: 20519625
[TBL] [Abstract][Full Text] [Related]
54. Wiskott-Aldrich syndrome protein (WASp) and N-WASp are involved in the regulation of NK-cell migration upon NKG2D activation.
Serrano-Pertierra E; Cernuda-Morollón E; López-Larrea C
Eur J Immunol; 2012 Aug; 42(8):2142-51. PubMed ID: 22585739
[TBL] [Abstract][Full Text] [Related]
55. Cytotoxic T lymphocytes and natural killer cells display impaired cytotoxic functions and reduced activation in patients with alcoholic hepatitis.
Støy S; Dige A; Sandahl TD; Laursen TL; Buus C; Hokland M; Vilstrup H
Am J Physiol Gastrointest Liver Physiol; 2015 Feb; 308(4):G269-76. PubMed ID: 25501547
[TBL] [Abstract][Full Text] [Related]
56. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells.
Banerjee P; Feuer G; Barker E
J Virol; 2007 Sep; 81(18):9707-17. PubMed ID: 17609265
[TBL] [Abstract][Full Text] [Related]
57. Measurement of NK activity in whole blood by the CD69 up-regulation after co-incubation with K562, comparison with NK cytotoxicity assays and CD107a degranulation assay.
Dons'koi BV; Chernyshov VP; Osypchuk DV
J Immunol Methods; 2011 Sep; 372(1-2):187-95. PubMed ID: 21839083
[TBL] [Abstract][Full Text] [Related]
58. WITHDRAWN: Natural Killer Cell Activating Receptor NKG2D Is Involved in the Immunosuppressant Effect of Mycophenolate Mofetil and Infection of Hepatitis B Virus.
Dong S; Geng L; Shen MD; Zheng SS
Transplant Proc; 2015; 47(6):1796-801. PubMed ID: 26293053
[TBL] [Abstract][Full Text] [Related]
59. Blocking expression of inhibitory receptor NKG2A overcomes tumor resistance to NK cells.
Kamiya T; Seow SV; Wong D; Robinson M; Campana D
J Clin Invest; 2019 May; 129(5):2094-2106. PubMed ID: 30860984
[TBL] [Abstract][Full Text] [Related]
60. High frequency of activated natural killer and natural killer T-cells in patients with new onset of type 2 diabetes mellitus.
Guo H; Xu B; Gao L; Sun X; Qu X; Li X; Liu S; Feng J; Wang J; Tang Y; Yan G; Gao X; Jiang Y
Exp Biol Med (Maywood); 2012 May; 237(5):556-62. PubMed ID: 22547395
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
